US Regulators Approve 1st Treatment for Ebola Virus

US Regulators Approve 1st Treatment for Ebola Virus
A vial of Regeneron's Inmazeb medication, approved by the U.S. Food and Drug Administration on Oct. 14, 2020. Regeneron via AP
|Updated:

U.S. regulators Wednesday approved the first drug for the treatment of Ebola.

The Food and Drug Administration OK'd the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola virus strain, the most deadly of six known types. It typically kills 60% to 90% of patients.